Overview of Upcoming Conferences
SAN DIEGO, Travere Therapeutics, Inc. (NASDAQ: TVTX) has announced their participation in several noteworthy investor conferences this month. This engagement illustrates the company's continued efforts to connect with investors and stakeholders in the biopharmaceutical sector. Here’s a closer look at the significant conferences they will be attending:
Key Events in November
First on the agenda is the Guggenheim Securities Healthcare Innovation Conference, scheduled for November 11. Travere's management team is set to present at 2:30 p.m. ET, providing insights into the company’s developments and future prospects within the industry.
Following this, the Jefferies London Healthcare Conference will take place on November 20, where they will present at 8:30 a.m. GMT, further showcasing their commitment to broadening their reach and impact.
Engagement and Accessibility
Live presentations, as well as replays, will be available for those interested in learning more about Travere Therapeutics. Investors can view these webcasts on the Investor page of Travere’s website, ensuring that audiences can stay informed about the company’s initiatives and strategies.
About Travere Therapeutics
Travere Therapeutics is dedicated to making a significant impact within the realm of rare diseases. The mission of the company revolves around improving the lives of patients and their families as they face these unique health challenges. Travere Therapeutics understands the urgency for effective treatment options and actively collaborates with the rare disease community to create viable solutions.
A Commitment to Innovation
The commitment displayed by Travere extends beyond mere product development; it is about forging meaningful relationships within the patient community. By gathering diverse perspectives and working closely with stakeholders, Travere aims to not only deliver therapies but also bring hope and support to those in need.
Contact Information
For further inquiries regarding investor relations or media engagement, Travere has established contacts to streamline communication:
- Investors: 888-969-7879
Email: IR@travere.com - Media: 888-969-7879
Email: mediarelations@travere.com
Frequently Asked Questions
What is the purpose of the upcoming investor presentations?
The presentations aim to provide insights into Travere's initiatives and engage with the investment community about their ongoing projects.
Where can I access the live webcasts of the presentations?
Investors can access live webcasts on the Investor page of Travere’s website, along with replays available for up to 30 days post-event.
What is the focus of Travere Therapeutics?
Travere Therapeutics focuses on developing therapies for rare diseases, striving to improve the lives of patients and their families.
How can I contact Travere for investor inquiries?
Interested parties can reach out to Travere investor relations at 888-969-7879 or via email at IR@travere.com.
What type of collaboration does Travere engage in?
Travere collaborates closely with the rare disease community to understand needs and develop impactful therapies that offer real hope to patients.